RU2012105453A - Изотиозолы для лечения состояний глаз - Google Patents

Изотиозолы для лечения состояний глаз Download PDF

Info

Publication number
RU2012105453A
RU2012105453A RU2012105453/15A RU2012105453A RU2012105453A RU 2012105453 A RU2012105453 A RU 2012105453A RU 2012105453/15 A RU2012105453/15 A RU 2012105453/15A RU 2012105453 A RU2012105453 A RU 2012105453A RU 2012105453 A RU2012105453 A RU 2012105453A
Authority
RU
Russia
Prior art keywords
treatment
isotiosols
eye states
condition
eye
Prior art date
Application number
RU2012105453/15A
Other languages
English (en)
Russian (ru)
Inventor
Веена ВИСВАНАТ
Джон Е. ДОНЕЛЛО
Original Assignee
Аллерган, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Аллерган, Инк. filed Critical Аллерган, Инк.
Publication of RU2012105453A publication Critical patent/RU2012105453A/ru

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
RU2012105453/15A 2009-08-11 2010-08-10 Изотиозолы для лечения состояний глаз RU2012105453A (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US23304709P 2009-08-11 2009-08-11
US61/233,047 2009-08-11
PCT/US2010/044946 WO2011019678A1 (en) 2009-08-11 2010-08-10 Isothiozoles for treating conditions of the eye

Publications (1)

Publication Number Publication Date
RU2012105453A true RU2012105453A (ru) 2013-09-20

Family

ID=43007053

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2012105453/15A RU2012105453A (ru) 2009-08-11 2010-08-10 Изотиозолы для лечения состояний глаз

Country Status (11)

Country Link
US (1) US20110039900A1 (show.php)
EP (1) EP2464351A1 (show.php)
JP (1) JP2013501794A (show.php)
KR (1) KR20120081585A (show.php)
CN (1) CN102695505A (show.php)
AU (1) AU2010282698A1 (show.php)
BR (1) BR112012003284A8 (show.php)
CA (1) CA2770894A1 (show.php)
IN (1) IN2012DN01846A (show.php)
RU (1) RU2012105453A (show.php)
WO (1) WO2011019678A1 (show.php)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2768652C1 (ru) 2014-09-17 2022-03-24 Паноптика, Инк. Офтальмологические составы для доставки лекарств и защиты переднего отдела глаза
IL251949A0 (en) 2017-04-26 2017-07-31 Medical Res Infrastructure & Health Services Fund Tel Aviv Medical Ct Small organic molecules for use in the treatment of neuro-inflammatory diseases
US12083114B2 (en) 2018-12-19 2024-09-10 Disarm Therapeutics, Inc. Inhibitors of SARM1 in combination with neuro-protective agents

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4166452A (en) 1976-05-03 1979-09-04 Generales Constantine D J Jr Apparatus for testing human responses to stimuli
US4256108A (en) 1977-04-07 1981-03-17 Alza Corporation Microporous-semipermeable laminated osmotic system
US4265874A (en) 1980-04-25 1981-05-05 Alza Corporation Method of delivering drug with aid of effervescent activity generated in environment of use
US6114355A (en) * 1993-03-01 2000-09-05 D'amato; Robert Methods and compositions for inhibition of angiogenesis
US6989451B2 (en) * 2002-06-04 2006-01-24 Valeant Research & Development Heterocyclic compounds and uses thereof
CA2582247C (en) * 2004-10-20 2014-02-11 Applied Research Systems Ars Holding N.V. 3-arylamino pyridine derivatives
EP2068856A2 (en) * 2006-07-25 2009-06-17 Alcon Research, Ltd. Antagonists of endothelial differentiation gene subfamily 3 (edg-3, s1p3) receptors for prevention and treatment of ocular disorders

Also Published As

Publication number Publication date
JP2013501794A (ja) 2013-01-17
BR112012003284A2 (pt) 2016-03-01
WO2011019678A1 (en) 2011-02-17
KR20120081585A (ko) 2012-07-19
CA2770894A1 (en) 2011-02-17
AU2010282698A1 (en) 2012-03-15
BR112012003284A8 (pt) 2016-05-17
US20110039900A1 (en) 2011-02-17
EP2464351A1 (en) 2012-06-20
CN102695505A (zh) 2012-09-26
IN2012DN01846A (show.php) 2015-08-21

Similar Documents

Publication Publication Date Title
ATE502633T1 (de) Cyclosporins zur behandlung und vorbeugung von augenerkrankungen
UA113627C2 (xx) Кристалічна форма циклоспорину a, фармацевтична композиція та спосіб лікування
MY159463A (en) Method and composition for treating ocular hypertension and glaucoma
EA201690066A1 (ru) Соединения пиримидиндиона
EA201790377A1 (ru) Антитела к глюкагону и их применения
WO2013123265A8 (en) Masked ocular device for implantation adjacent to an intraocular lens
NZ757815A (en) Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity
EA201390772A1 (ru) Новые соли и полиморфные формы афатиниба
EA201101111A1 (ru) Алкиламинозамещенные дицианопиридины и их пролекарства в виде сложных эфиров с аминокислотами
RU2010144637A (ru) Замещенные гамма-лактамы в качестве терапевтических агентов
EA201491334A1 (ru) Композиции и способы для лечения метаболических расстройств
WO2016014533A3 (en) Devices and methods for fixation of animal tissue
EA201100462A1 (ru) Серосвязанные соединения для лечения офтальмологических заболеваний и расстройств
PH12014500967A1 (en) A medicament for treating anterior eye disease comprising rebamipide and a tear-retaining agent
EA201190337A1 (ru) Способ лечения
MX2016006334A (es) Metodos de tratamiento de enfermedades oculares con un implante para la administracion sostenida de farmacos.
RU2012105453A (ru) Изотиозолы для лечения состояний глаз
RU2010141793A (ru) Терапевтические замещенные циклопентаны
EA201001405A1 (ru) Стимуляторы секреции инсулина - производные пиридопиразинонов, способы их получения и их применение для лечения диабета
ZA202402868B (en) Treatment method for retinal degeneration
EA201500143A1 (ru) Терапия макулярной дегенерации на основе баклофена и акампросата
EA201200028A1 (ru) Альфа-1 мультимеры hla-g и их фармацевтическое применение
MX2019004200A (es) Terapia de combinacion.
GB201107576D0 (en) Novel compounds and methods for use in medicine
MY157434A (en) Method for improving bioavailability of latanoprost

Legal Events

Date Code Title Description
FA92 Acknowledgement of application withdrawn (lack of supplementary materials submitted)

Effective date: 20141020